Strategies to Reduce Oxidative Stress in Glaucoma Patients
Background: Primary open-angle glaucoma (POAG) is a multifactorial pathology involving a variety of pathogenic mechanisms, including oxidative/nitrosative stress. This latter is the consequence of the imbalance between excessive formation and insufficient protection against reactive oxygen/nitrogen...
Gespeichert in:
Veröffentlicht in: | Current neuropharmacology 2018-01, Vol.16 (7), p.903-918 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 918 |
---|---|
container_issue | 7 |
container_start_page | 903 |
container_title | Current neuropharmacology |
container_volume | 16 |
creator | Pinazo-Duran, Maria D Shoaie-Nia, Kian Zanon-Moreno, Vicente Sanz-Gonzalez, Silva M Del Castillo, Javier Benitez Garcia-Medina, Jose J |
description | Background: Primary open-angle glaucoma (POAG) is a multifactorial pathology
involving a variety of pathogenic mechanisms, including oxidative/nitrosative stress. This latter is
the consequence of the imbalance between excessive formation and insufficient protection against
reactive oxygen/nitrogen species.
Objective: Our main goal is to gather molecular information to better managing pathologic variants
that may determine the individual susceptibility to oxidative/nitrosative stress (OS/NS) and POAG.
Method: An extensive search of the scientific literature was conducted using PUBMED, the Web of
Science, the Cochrane Library, and other references on the topic of POAG and OS/NS from human
and animal model studies published between 2010 and 2017. Finally, 152 works containing relevant
information that may help understanding the role of antioxidants, essential fatty acids, natural compounds
and other similar strategies for counteracting OS/NS in POAG were considered.
Results: A wide variety of studies have proven that antioxidants, among them vitamins B3, C and E,
Coenzyme Q10 or melatonin, ω-3/ω-6 fatty acids and other natural compounds (such as coffee,
green tea, bear bile, gingko biloba, coleus, tropical fruits, etc.,) may help regulating the intraocular
pressure as well as protecting the retinal neurons against OS/NS in POAG.
Conclusion: Based on the impact of antioxidants and ω-3/ω-6 fatty acids at the molecular level in
the glaucomatous anterior and posterior eye segments, further studies are needed by integrating all
issues involved in glaucoma pathogenesis, endogenous and exogenous risk factors and their interactions
that will allow us to reach newer effective biotherapies for preventing glaucomatous irreversible
blindness. |
doi_str_mv | 10.2174/1570159X15666170705101910 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6120109</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2188099713</sourcerecordid><originalsourceid>FETCH-LOGICAL-b632t-34fe36b0cfad3b989d29143e9591496acdb40365aaca1022d764f7dcddeae3753</originalsourceid><addsrcrecordid>eNp1kEuP1DAQhCMEYh_wF1AQ54Dbju2YAxJawS7SSot4SNxajt2ZyZJJgu3MwJ0fjodZRnDg1C3VV92lKoqnwJ5z0PULkJqBNF9AKqVAM80kMDDA7hWn0GhZKTDsft4zV-3Bk-IsxlvGuGy4flic8EZpXRt5Wrz8mIJNtOoplmkqP5BfHJU333tvU7-lMssUY9mP5eVgFzdtbPk-KzSm-Kh40Nkh0uO7eV58fvvm08VVdX1z-e7i9XXVKsFTJeqOhGqZ66wXrWmM5wZqQUbmYZR1vq2ZUNJaZ4Fx7rWqO-2d92RJaCnOi1eHu_PSbsi7_DvYAefQb2z4gZPt8V9l7Ne4mraogDNgJh94dncgTN8WiglvpyWMOTNyaBpmjAaRKXOgXJhiDNQdPwDDfe3439qz98nfEY_OPz1n4OcBaHPGtd1Elyt0dATXKc242-2QlkBfbaSBXMJcN04zjUsY8j6m7MV5PeOKxkBoQ-rdQNjHOP7OhvtwuJ2GZUMIai8shBrjbFeEhgnxCwa1seY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2188099713</pqid></control><display><type>article</type><title>Strategies to Reduce Oxidative Stress in Glaucoma Patients</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Pinazo-Duran, Maria D ; Shoaie-Nia, Kian ; Zanon-Moreno, Vicente ; Sanz-Gonzalez, Silva M ; Del Castillo, Javier Benitez ; Garcia-Medina, Jose J</creator><creatorcontrib>Pinazo-Duran, Maria D ; Shoaie-Nia, Kian ; Zanon-Moreno, Vicente ; Sanz-Gonzalez, Silva M ; Del Castillo, Javier Benitez ; Garcia-Medina, Jose J</creatorcontrib><description>Background: Primary open-angle glaucoma (POAG) is a multifactorial pathology
involving a variety of pathogenic mechanisms, including oxidative/nitrosative stress. This latter is
the consequence of the imbalance between excessive formation and insufficient protection against
reactive oxygen/nitrogen species.
Objective: Our main goal is to gather molecular information to better managing pathologic variants
that may determine the individual susceptibility to oxidative/nitrosative stress (OS/NS) and POAG.
Method: An extensive search of the scientific literature was conducted using PUBMED, the Web of
Science, the Cochrane Library, and other references on the topic of POAG and OS/NS from human
and animal model studies published between 2010 and 2017. Finally, 152 works containing relevant
information that may help understanding the role of antioxidants, essential fatty acids, natural compounds
and other similar strategies for counteracting OS/NS in POAG were considered.
Results: A wide variety of studies have proven that antioxidants, among them vitamins B3, C and E,
Coenzyme Q10 or melatonin, ω-3/ω-6 fatty acids and other natural compounds (such as coffee,
green tea, bear bile, gingko biloba, coleus, tropical fruits, etc.,) may help regulating the intraocular
pressure as well as protecting the retinal neurons against OS/NS in POAG.
Conclusion: Based on the impact of antioxidants and ω-3/ω-6 fatty acids at the molecular level in
the glaucomatous anterior and posterior eye segments, further studies are needed by integrating all
issues involved in glaucoma pathogenesis, endogenous and exogenous risk factors and their interactions
that will allow us to reach newer effective biotherapies for preventing glaucomatous irreversible
blindness.</description><identifier>ISSN: 1570-159X</identifier><identifier>EISSN: 1875-6190</identifier><identifier>DOI: 10.2174/1570159X15666170705101910</identifier><identifier>PMID: 28677495</identifier><language>eng</language><publisher>United Arab Emirates: Bentham Science Publishers Ltd</publisher><subject>Animal models ; Animals ; Antioxidants ; Antioxidants - therapeutic use ; Bile ; Blindness ; Coenzyme Q10 ; Coffee ; Fatty acids ; Glaucoma ; Glaucoma - drug therapy ; Glaucoma - metabolism ; Green tea ; Humans ; Melatonin ; Oxidative stress ; Oxidative Stress - drug effects ; Oxidative Stress - physiology ; Reactive nitrogen species ; Reactive oxygen species ; Retina ; Risk factors ; Vitamins</subject><ispartof>Current neuropharmacology, 2018-01, Vol.16 (7), p.903-918</ispartof><rights>Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.</rights><rights>Copyright Bentham Science Aug 2018</rights><rights>2018 Bentham Science Publishers 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b632t-34fe36b0cfad3b989d29143e9591496acdb40365aaca1022d764f7dcddeae3753</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120109/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120109/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28677495$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pinazo-Duran, Maria D</creatorcontrib><creatorcontrib>Shoaie-Nia, Kian</creatorcontrib><creatorcontrib>Zanon-Moreno, Vicente</creatorcontrib><creatorcontrib>Sanz-Gonzalez, Silva M</creatorcontrib><creatorcontrib>Del Castillo, Javier Benitez</creatorcontrib><creatorcontrib>Garcia-Medina, Jose J</creatorcontrib><title>Strategies to Reduce Oxidative Stress in Glaucoma Patients</title><title>Current neuropharmacology</title><addtitle>CN</addtitle><description>Background: Primary open-angle glaucoma (POAG) is a multifactorial pathology
involving a variety of pathogenic mechanisms, including oxidative/nitrosative stress. This latter is
the consequence of the imbalance between excessive formation and insufficient protection against
reactive oxygen/nitrogen species.
Objective: Our main goal is to gather molecular information to better managing pathologic variants
that may determine the individual susceptibility to oxidative/nitrosative stress (OS/NS) and POAG.
Method: An extensive search of the scientific literature was conducted using PUBMED, the Web of
Science, the Cochrane Library, and other references on the topic of POAG and OS/NS from human
and animal model studies published between 2010 and 2017. Finally, 152 works containing relevant
information that may help understanding the role of antioxidants, essential fatty acids, natural compounds
and other similar strategies for counteracting OS/NS in POAG were considered.
Results: A wide variety of studies have proven that antioxidants, among them vitamins B3, C and E,
Coenzyme Q10 or melatonin, ω-3/ω-6 fatty acids and other natural compounds (such as coffee,
green tea, bear bile, gingko biloba, coleus, tropical fruits, etc.,) may help regulating the intraocular
pressure as well as protecting the retinal neurons against OS/NS in POAG.
Conclusion: Based on the impact of antioxidants and ω-3/ω-6 fatty acids at the molecular level in
the glaucomatous anterior and posterior eye segments, further studies are needed by integrating all
issues involved in glaucoma pathogenesis, endogenous and exogenous risk factors and their interactions
that will allow us to reach newer effective biotherapies for preventing glaucomatous irreversible
blindness.</description><subject>Animal models</subject><subject>Animals</subject><subject>Antioxidants</subject><subject>Antioxidants - therapeutic use</subject><subject>Bile</subject><subject>Blindness</subject><subject>Coenzyme Q10</subject><subject>Coffee</subject><subject>Fatty acids</subject><subject>Glaucoma</subject><subject>Glaucoma - drug therapy</subject><subject>Glaucoma - metabolism</subject><subject>Green tea</subject><subject>Humans</subject><subject>Melatonin</subject><subject>Oxidative stress</subject><subject>Oxidative Stress - drug effects</subject><subject>Oxidative Stress - physiology</subject><subject>Reactive nitrogen species</subject><subject>Reactive oxygen species</subject><subject>Retina</subject><subject>Risk factors</subject><subject>Vitamins</subject><issn>1570-159X</issn><issn>1875-6190</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kEuP1DAQhCMEYh_wF1AQ54Dbju2YAxJawS7SSot4SNxajt2ZyZJJgu3MwJ0fjodZRnDg1C3VV92lKoqnwJ5z0PULkJqBNF9AKqVAM80kMDDA7hWn0GhZKTDsft4zV-3Bk-IsxlvGuGy4flic8EZpXRt5Wrz8mIJNtOoplmkqP5BfHJU333tvU7-lMssUY9mP5eVgFzdtbPk-KzSm-Kh40Nkh0uO7eV58fvvm08VVdX1z-e7i9XXVKsFTJeqOhGqZ66wXrWmM5wZqQUbmYZR1vq2ZUNJaZ4Fx7rWqO-2d92RJaCnOi1eHu_PSbsi7_DvYAefQb2z4gZPt8V9l7Ne4mraogDNgJh94dncgTN8WiglvpyWMOTNyaBpmjAaRKXOgXJhiDNQdPwDDfe3439qz98nfEY_OPz1n4OcBaHPGtd1Elyt0dATXKc242-2QlkBfbaSBXMJcN04zjUsY8j6m7MV5PeOKxkBoQ-rdQNjHOP7OhvtwuJ2GZUMIai8shBrjbFeEhgnxCwa1seY</recordid><startdate>20180101</startdate><enddate>20180101</enddate><creator>Pinazo-Duran, Maria D</creator><creator>Shoaie-Nia, Kian</creator><creator>Zanon-Moreno, Vicente</creator><creator>Sanz-Gonzalez, Silva M</creator><creator>Del Castillo, Javier Benitez</creator><creator>Garcia-Medina, Jose J</creator><general>Bentham Science Publishers Ltd</general><general>Benham Science Publishers</general><general>Bentham Science Publishers</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>5PM</scope></search><sort><creationdate>20180101</creationdate><title>Strategies to Reduce Oxidative Stress in Glaucoma Patients</title><author>Pinazo-Duran, Maria D ; Shoaie-Nia, Kian ; Zanon-Moreno, Vicente ; Sanz-Gonzalez, Silva M ; Del Castillo, Javier Benitez ; Garcia-Medina, Jose J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b632t-34fe36b0cfad3b989d29143e9591496acdb40365aaca1022d764f7dcddeae3753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Animal models</topic><topic>Animals</topic><topic>Antioxidants</topic><topic>Antioxidants - therapeutic use</topic><topic>Bile</topic><topic>Blindness</topic><topic>Coenzyme Q10</topic><topic>Coffee</topic><topic>Fatty acids</topic><topic>Glaucoma</topic><topic>Glaucoma - drug therapy</topic><topic>Glaucoma - metabolism</topic><topic>Green tea</topic><topic>Humans</topic><topic>Melatonin</topic><topic>Oxidative stress</topic><topic>Oxidative Stress - drug effects</topic><topic>Oxidative Stress - physiology</topic><topic>Reactive nitrogen species</topic><topic>Reactive oxygen species</topic><topic>Retina</topic><topic>Risk factors</topic><topic>Vitamins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pinazo-Duran, Maria D</creatorcontrib><creatorcontrib>Shoaie-Nia, Kian</creatorcontrib><creatorcontrib>Zanon-Moreno, Vicente</creatorcontrib><creatorcontrib>Sanz-Gonzalez, Silva M</creatorcontrib><creatorcontrib>Del Castillo, Javier Benitez</creatorcontrib><creatorcontrib>Garcia-Medina, Jose J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Current neuropharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pinazo-Duran, Maria D</au><au>Shoaie-Nia, Kian</au><au>Zanon-Moreno, Vicente</au><au>Sanz-Gonzalez, Silva M</au><au>Del Castillo, Javier Benitez</au><au>Garcia-Medina, Jose J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Strategies to Reduce Oxidative Stress in Glaucoma Patients</atitle><jtitle>Current neuropharmacology</jtitle><addtitle>CN</addtitle><date>2018-01-01</date><risdate>2018</risdate><volume>16</volume><issue>7</issue><spage>903</spage><epage>918</epage><pages>903-918</pages><issn>1570-159X</issn><eissn>1875-6190</eissn><abstract>Background: Primary open-angle glaucoma (POAG) is a multifactorial pathology
involving a variety of pathogenic mechanisms, including oxidative/nitrosative stress. This latter is
the consequence of the imbalance between excessive formation and insufficient protection against
reactive oxygen/nitrogen species.
Objective: Our main goal is to gather molecular information to better managing pathologic variants
that may determine the individual susceptibility to oxidative/nitrosative stress (OS/NS) and POAG.
Method: An extensive search of the scientific literature was conducted using PUBMED, the Web of
Science, the Cochrane Library, and other references on the topic of POAG and OS/NS from human
and animal model studies published between 2010 and 2017. Finally, 152 works containing relevant
information that may help understanding the role of antioxidants, essential fatty acids, natural compounds
and other similar strategies for counteracting OS/NS in POAG were considered.
Results: A wide variety of studies have proven that antioxidants, among them vitamins B3, C and E,
Coenzyme Q10 or melatonin, ω-3/ω-6 fatty acids and other natural compounds (such as coffee,
green tea, bear bile, gingko biloba, coleus, tropical fruits, etc.,) may help regulating the intraocular
pressure as well as protecting the retinal neurons against OS/NS in POAG.
Conclusion: Based on the impact of antioxidants and ω-3/ω-6 fatty acids at the molecular level in
the glaucomatous anterior and posterior eye segments, further studies are needed by integrating all
issues involved in glaucoma pathogenesis, endogenous and exogenous risk factors and their interactions
that will allow us to reach newer effective biotherapies for preventing glaucomatous irreversible
blindness.</abstract><cop>United Arab Emirates</cop><pub>Bentham Science Publishers Ltd</pub><pmid>28677495</pmid><doi>10.2174/1570159X15666170705101910</doi><tpages>16</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1570-159X |
ispartof | Current neuropharmacology, 2018-01, Vol.16 (7), p.903-918 |
issn | 1570-159X 1875-6190 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6120109 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
subjects | Animal models Animals Antioxidants Antioxidants - therapeutic use Bile Blindness Coenzyme Q10 Coffee Fatty acids Glaucoma Glaucoma - drug therapy Glaucoma - metabolism Green tea Humans Melatonin Oxidative stress Oxidative Stress - drug effects Oxidative Stress - physiology Reactive nitrogen species Reactive oxygen species Retina Risk factors Vitamins |
title | Strategies to Reduce Oxidative Stress in Glaucoma Patients |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T19%3A27%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Strategies%20to%20Reduce%20Oxidative%20Stress%20in%20Glaucoma%20Patients&rft.jtitle=Current%20neuropharmacology&rft.au=Pinazo-Duran,%20Maria%20D&rft.date=2018-01-01&rft.volume=16&rft.issue=7&rft.spage=903&rft.epage=918&rft.pages=903-918&rft.issn=1570-159X&rft.eissn=1875-6190&rft_id=info:doi/10.2174/1570159X15666170705101910&rft_dat=%3Cproquest_pubme%3E2188099713%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2188099713&rft_id=info:pmid/28677495&rfr_iscdi=true |